Medicare is changing again, and for federal retirees and employees, the updates could make retirement healthcare decisions more complicated than they already are.
The Centers for Medicare and Medicaid Services recently released a proposed rule outlining changes for the 2027 plan year. While much of the proposal is technical, the real-world impact comes down to one important point: coordinating FEHB coverage with Medicare is becoming more individualized and more difficult to evaluate with a one-size-fits-all approach.
For years, many federal retirees approached Medicare decisions with fairly simple assumptions. Some automatically enrolled in Part B alongside FEHB. Others skipped Medicare drug coverage because FEHB prescription benefits were already considered strong.
That calculation is becoming less straightforward.
One major area of change involves Medicare Part D prescription drug coverage. Medicare has already been moving toward lower and more predictable out-of-pocket drug costs through changes tied to the Inflation Reduction Act. The proposed 2027 rule continues that transition and further reshapes how prescription coverage works.
For federal retirees, the question is no longer simply whether FEHB drug coverage is “good enough.” The better question may be how a specific FEHB plan compares to a specific Medicare drug plan based on your medications, expected costs, and healthcare needs.
At the same time, Medicare Advantage plans may also become harder to compare.
The proposed rule would remove several quality measures from Medicare’s Star Ratings system and eliminate the Health Equity Index reward that currently factors into plan scores. While the system may become simpler on paper, some retirees may find the ratings less useful when trying to judge actual plan quality.
In practical terms, a five-star Medicare Advantage plan in the future may not represent the same level of overall performance retirees have come to expect under the current system.
Prescription drug costs may also become more stable from year to year, but that does not necessarily mean coverage will become cheaper overall. As insurers adjust to the new rules, premiums, formularies, and plan structures are likely to continue evolving.
The broader takeaway is that Medicare decisions are no longer something federal retirees can evaluate once and ignore for the next 20 years.
The relationship between FEHB, Medicare Part B, Medicare Advantage, and prescription drug coverage is changing, and retirees may need to revisit those decisions more regularly as rules and plan designs continue to evolve.
For federal employees nearing retirement, understanding how these moving pieces fit together may become just as important as understanding their pension or TSP withdrawal strategy.
A Federal Retirement Consultant (FRC®) can help you evaluate how Medicare and FEHB work together based on your situation and retirement goals. Schedule your complimentary benefits review today.
